Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elizabeth Rich
Phase I-Ii Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Loss of CD26 Protease Activity in Recipient Mice During Hematopoietic Stem Cell Transplantation Results in Improved Transplant Efficiency
Transfusion
Allergy
Immunology
Hematology
Related publications
Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation Using Fludarabine–melphalan Conditioning for Treatment of Mature T-Cell Lymphomas
Bone Marrow Transplantation
Transplantation
Hematology
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients With Non-Malignant Diseases: Preliminary Results of a Phase II Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced Intensity Conditioning With Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With Fludarabine/Melphalan in Patients With Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
Haematologica
Hematology
Allogeneic Hematopoietic Stem Cell Transplantation
Archives of Internal Medicine
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia
Cancer Control
Medicine
Oncology
Hematology
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (With Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
